Amylyx Pharmaceuticals, Inc.
AMLX
$9.24
$0.819.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.63% | -45.33% | -52.47% | -33.98% | -13.28% |
| Total Receivables | -95.16% | -98.55% | -98.65% | -94.12% | -87.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.92% | -29.02% | -14.18% | -47.00% | 15.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -42.80% | -47.35% | -59.23% | -43.50% | -23.55% |
|
|
|||||
| Total Current Assets | -42.80% | -47.35% | -59.23% | -43.50% | -23.55% |
| Net Property, Plant & Equipment | 47.50% | -63.72% | -57.39% | -49.25% | -41.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.12% | 20.46% | -96.83% | -92.47% | -93.67% |
| Total Assets | -41.41% | -47.38% | -62.58% | -46.27% | -26.77% |
|
|
|||||
| Total Accounts Payable | -33.52% | -77.58% | -86.68% | -76.66% | -79.94% |
| Total Accrued Expenses | -72.17% | -82.22% | -58.51% | 36.20% | 68.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -71.93% | -54.37% | -32.74% | -10.40% | 10.39% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -69.43% | -80.43% | -65.38% | 18.19% | 9.36% |
|
|
|||||
| Total Current Liabilities | -69.43% | -80.43% | -65.38% | 18.19% | 9.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 586.14% | -76.34% | -76.62% | -76.82% | -75.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -62.29% | -80.37% | -65.64% | 13.13% | 5.40% |
|
|
|||||
| Common Stock & APIC | 12.34% | 12.80% | 4.52% | 5.01% | 5.70% |
| Retained Earnings | -37.79% | -51.65% | -98.95% | -83.79% | -50.18% |
| Treasury Stock & Other | 668.04% | -- | -146.70% | 524.50% | -34.72% |
| Total Common Equity | -35.76% | -37.92% | -61.99% | -53.11% | -32.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.76% | -37.92% | -61.99% | -53.11% | -32.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.76% | -37.92% | -61.99% | -53.11% | -32.37% |
|
|
|||||